PODD Earnings Prediction
The chart below shows how PODD performed 10 days before and after its earnings report, based on data from the past quarters. Typically, PODD sees a -1.58% change in stock price 10 days leading up to the earnings, and a -0.47% change 10 days following the report. On the earnings day itself, the stock moves by +0.30%. This data can give you a slight idea of what to expect for the next quarter's release.
PODD Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
543.90M
25.70%
11.34%
Gross Margin
69.33%
2.29%
2.35%
Operating Margin
16.57%
30.88%
48.21%
Net Margin
14.25%
18.85%
-63.09%
EPS
1.08
45.95%
-58.30%
No Data Available
PODD Earnings Analysis
Insulet Corporation Corporation (PODD.O) Earnings Conference Call
Positive
Record Revenue Achievement: In the third quarter, we achieved our highest quarter of total revenue dollars, driven by total Omnipod revenue growth of 26%, including U.S. growth of 23% and international growth of 35%.
Strong Financial Performance: We delivered another strong quarter of financial results and achieved several outstanding milestones throughout our business.
Record Revenue Achievement: We are on track to close out another impressive year and generate over $2 billion in fully year revenue for the first time in Insulet's history.
Customer Growth Expansion: In the third quarter, our global new customer starts grew sequentially and over prior year, including sequential growth in the U.S. in both the type 1 and type 2 populations.
Omnipod Revenue Surge: We achieved 25% revenue growth, driven by total Omnipod growth of 26%.
Negative
Record Revenue Achievement: In the third quarter, we achieved our highest quarter of total revenue dollars, driven by total Omnipod revenue growth of 26%, including U.S. growth of 23% and international growth of 35%.
Customer Growth Trends: Our global new customer starts grew sequentially and over prior year, including sequential growth in the U.S. in both the type 1 and type 2 populations.
Cash and Credit Availability: We ended the quarter with approximately $900 million in cash and the full $300 million available under our credit facility.
Omnipod Revenue Projections: We expect total Omnipod revenue growth of 13% to 16% and total company growth of 12% to 15%. For U.S. Omnipod, we expect growth of 9% to 12%.
Remaining Balance Release: We anticipate releasing the remaining balance of $15 million in the fourth quarter.
PODD FAQs
How does PODD typically perform around its earnings report dates?
Is Insulet Corporation (PODD) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
PODD Earning Call Sentiment
Insulet Corporation (PODD) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
PODD.O
-1.9%Positive
The earnings call indicates strong revenue growth, particularly in the Omnipod segment, and raised guidance for 2024. Operating and gross margins have improved, and the international expansion is promising. Although competitive and regulatory risks exist, the FDA clearance for type 2 diabetes expansion is a positive. The absence of shareholder return initiatives is a minor drawback, but overall, the company's strong financial performance and optimistic guidance suggest a positive stock price movement.
